Endpoints News 2025-11-26 Imfinzi's latest label expansion; FDA seeks more information on BiomX's nebulizer
Endpoints News 2025-11-25 CMS unveils IRA prices for Ozempic, Wegovy and other drugs from second round
Endpoints News 2025-11-25 Pharma faces deadline to bring IRA fight to Supreme Court as first set of negotiated prices looms
Endpoints News 2025-11-25 FDA OKs Sarepta study of new immune suppression approach with Elevidys; Gilead buys preclinical TREX1 program
Endpoints News 2025-11-25 Novo Nordisk’s amycretin cuts body weight, blood sugar in Phase 2 diabetes trial